The TiP-HepC Scientific Advisory Committee is comprised of experts who have proven research and advocacy expertise for HCV treatment options in pregnancy. The TiP-HepC Scientific Advisory Committee will review and advise CGHE and the study principal investigators on the study design and procedures, advise on potential sources of data to the registry and facilitate communication with potential data contributors, review interim data reports and provide interpretation of data, advise on dissemination of study/project findings and key messaging, provide recommendations on policy targets or implications, and advise on registry utility and sustainability for long-term surveillance or monitoring.